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ABSTRACT Recent molecular-dynamics simulations have suggested that the arginine-rich HIV Tat peptides translocate by 
destabilizing and inducing transient pores in phospholipid bilayers. In this pathway for peptide translocation, Arg residues 
play a fundamental role not only in the binding of the peptide to the surface of the membrane, but also in the destabilization 
and nucleation of transient pores across the bilayer. Here we present a molecular-dynamics simulation of a peptide composed 
of nine Args (Arg-9) that shows that this peptide follows the same translocation pathway previously found for the Tat peptide. We 
test experimentally the hypothesis that transient pores open by measuring ionic currents across phospholipid bilayers and cell 
membranes through the pores induced by Arg-9 peptides. We find that Arg-9 peptides, in the presence of an electrostatic poten­
tial gradient, induce ionic currents across planar phospholipid bilayers, as well as in cultured osteosarcoma cells and human 
smooth muscle cells. Our results suggest that the mechanism of action of Arg-9 peptides involves the creation of transient pores 
in lipid bilayers and cell membranes.
INTRODUCTION
Cell-penetrating peptides (CPPs) are short sequences of 
amino acids (<30) that are capable of entering most mamma­
lian cells. CPPs have the special property of carrying with 
them cargoes of a wide range of molecular sizes, such as 
proteins, oligonucleotides, and even 200 nm liposomes 
(1-7). Many CPPs are highly cationic and hydrophilic, and 
exhibit no or relatively low amphipathicity when compared 
with other peptides that are known to interact with and per- 
meabilize phospholipid membranes. The translocation 
mechanism by which these peptides are able to enter cells 
has remained elusive since they were first discovered 
(1,2,8,9). There is ample evidence suggesting that the uptake 
is independent of metabolic energy and does not involve any 
specific cell receptor (2). Other reports indicate that the 
uptake may involve lipid raft-mediated endocytotic path­
ways (10-12). Even when the uptake initially follows an 
endocytotic pathway, arg-rich CPPs are still able to breach 
the endosome membrane barrier to reach, for example, the 
cell nucleus (13).
A common feature of cationic CPPs is that they form 
a rapid and tight interaction with extracellular glycosamino­
glycans, such as heparan sulfate, heparin, and chondroitin 
sulfate B (13). However, whereas a significant part of the 
uptake of CPPs might involve heparan sulfate receptors, 
efficient internalization is observed even in their absence 
(14). Linthennore. these peptides are capable of entering 
giant unilamellar vesicles (GUVs) composed of model phos­
pholipid membranes (15-18). These results suggest that
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these peptides can directly interact with the phospholipid 
bilayer, altering its resting structure, and that these changes 
facilitate peptide translocation. Taken together, these find­
ings suggest that the binding of highly cationic CPPs to 
anionic plasma membrane components, such as phosphate 
groups, could be an important step for effective peptide 
translocation across a phospholipid bilayer or the cell 
membrane.
The relevance of peptide-phosphate interactions can be 
understood through a theoretical model that we recently 
proposed for the translocation of the Tat peptide (19). This 
model shows how these peptides may be able to nucleate 
a pore and diffuse across a phospholipid bilayer. It also high­
lights the special importance of the charged amino acids in 
the translocation mechanism, where the Arg and Lys side 
chains initially bind to the phospholipid phosphate groups, 
producing strong distortions to the bilayer relative to their 
resting structure that lead to the formation of a pore. The rele­
vance of the Arg-phosphate interaction has been highlighted 
in several reports indicating, for example, that poly-Arg 
peptides translocate more efficiently than poly-Lys peptides 
and the Tat peptide (9,20). The interaction of Arg amino 
acids with phosphate groups of the plasma membrane plays 
a fundamental role in other physiological processes, such 
as the voltage gating of potassium ion channels (21,22). It 
has been suggested that the use of Arg in voltage sensors 
may be an adaptation to the phospholipid composition 
of cell membranes (23). The importance of guanidinium- 
phospholipid interactions has also led to intense theoretical 
research (24—28).
Several Arg-rich antimicrobial peptides can also disrupt 
and form pores in lipid bilayers and bacterial cell membranes 
(29-31). It is known that antimicrobial peptides are able to
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translocate across the bacterial plasma membrane in an 
energy-independent manner. Since CPPs also seem to be 
capable of translocating in an energy-independent manner, 
they could share a similar pore-opening mechanism (2,19, 
32,33). However, an important difference between hydro­
philic CPPs and antimicrobial peptides is the lack of hydro- 
phobic residues in the former case. It has been shown that 
poly-Arg peptides composed of nine Arg amino acids (Arg-9) 
are able to translocate across cells very efficiently (34).
Based on the theoretical translocation pathway found for 
Tat and Arg-9, the central hypothesis of the experimental 
work presented here is as follows: If Arg-rich CPPs disturb 
and induce pores in phospholipid membranes, then ions 
should be able to flow across lipid membranes through 
these pores. Therefore, applying an electrostatic potential 
should produce ionic currents through the pores induced 
by CPPs across phospholipid bilayers and cell membranes. 
Consistent with this hypothesis, we detected ionic currents 
induced by Arg-9 on 1), model phospholipid membranes 
using the planar phospholipid bilayers method (35); and 
2), on freshly isolated human umbilical artery (HUA) smooth 
muscle cells and on cultured osteosarcoma cells using 
the patch-clamp technique (36). We found that the ionic 
permeability of phospholipid bilayers and cell membranes 
is increased by the presence of the Arg-9 peptides. We 
also explored other peptides and solution conditions that 
alter this permeability.
This work covers systems with different degrees of 
complexity, ranging from simulations of very simple systems 
to experiments on live mammalian cells. The molecular 
dynamics (MD) studies reported previously for Tat peptides 
(19) and here for Arg-9 peptides were conducted on simple 
systems containing a single phospholipid (1,2-dioleoyl-sn- 
glycero-3-phosphocholine (DOPC)), a few peptides, and 
water. Cell membranes and model membranes are usually 
composed of multiple lipids (33,37) and modified lipids. 
Here, we experimentally study a series of systems that are as 
simple as the systems modeled computationally, systems that 
contain lipid mixtures containing 1,2-Dioleoyl-sn-Glycero- 
3-|Phospho-/«r-(l-glycerol) | (DOPG) (e.g., 3:1 DOPC/ 
DOPG), and mammalian cells under different salt and pH 
conditions. This allows us to present physical, chemical, 
and biological details of the interactions between Arg-rich 
peptides and the cell membrane that we believe are essential 
to unveil the cell translocation pathway for CPPs.
MATERIALS AND METHODS
MD simulations
MD simulations were performed to study the translocation mechanism of 
Arg-9 peptides across model membranes. The Arg-9 peptides were placed 
in a periodically repeating box containing water molecules and a preequili­
brated lipid membrane composed of DOPC lipids (38,39). The peptides 
were placed near one side of the bilayer such that the Arg-9 peptides would 
bind mostly to one layer of the bilayer. These configurations are away from 
equilibrium. We explored how the systems relax from these configurations. 
Due to periodic boundary conditions, there are two paths by which an Arg-9 
peptide on one layer can move to bind the other layer: one that requires trans­
location, and one that requires detachment from a lipid layer and diffusion of 
the Arg-9 peptide from the initial configuration near the water-bilayer 
boundary on one layer to the other layer. Our calculations include a large 
number of water molecules such that binding to the proximal layer, given 
the initial conditions that we selected, is favored. We assume that the 
Arg-9 peptide remains fully charged throughout the simulation, consistent 
with observations describing a lack of changes in the pKa of buried Arg 
side chains in the interior of proteins. Potential of mean force calculations 
have shown that a single Arg side chain may adopt the protonated state in 
a lipid bilayer (26,40,41). MacCallum et al. (40) found that the cost of insert­
ing a second charged amino acid side chain into a lipid bilayer is much less 
than for the first, and therefore it is reasonable for us to assume that Arg-9 
will remain fully charged. The total length of the simulation was 500 ns. 
All simulations were performed using the GROM ACS package (42). The 
simulated system consists of four Arg-9 peptides, 92 DOPC phospholipid 
molecules, and 8795 water molecules. More details are provided in the Sup­
porting Material.
The experimental techniques included planar lipid bilayers, with bilayers 
composed of 100% DOPC and 3:1 DOPC/DOPG lipid mixtures. Patch­
clamp measurements were conducted in cultured osteosarcoma cells and 
human smooth muscle cells freshly isolated from the umbilical artery. All 
experiments measured currents in the presence and absence of Arg-9 
peptides and DAP-9 peptides under various conditions. The experimental 
methods are described in more detail in the Supporting Material.
RESULTS AND DISCUSSION
Theoretical model
We recently proposed a model for the translocation of the 
HIV-1 Tat peptide based on MD simulations (19). This model 
shows how these peptides are able to diffuse across phospho­
lipid bilayers. It consists of four basic steps: 1), the peptides 
bind to the surface of the bilayer, attracted by the phosphate 
groups of the phospholipids; 2), as the surface concentration 
of peptides increases, the arrangement of lipids is strongly 
distorted compared to that in the resting membrane; 3), an 
Arg side chain translocates to the distal layer, nucleating the 
formation of a water pore; and 4), a few peptides translocate 
by diffusing on the surface of the pore and the pore closes. 
This model highlights the central role of the Arg amino acids, 
including their strong attachment to the phosphate groups and 
their ability to induce strong distortions to the structure of 
the phospholipid bilayer. It has been reported that Arg-9 
peptides internalize more efficiently than Tat peptides. There­
fore, a natural question is, do peptides composed entirely of 
Arg amino acids such as Arg-9 follow a translocation pathway 
similar to that of the Tat peptide? In Fig. 1 are shown four 
snapshots extracted from this MD simulation, in which it 
can be seen that Arg-9 follows the same mechanism previ­
ously described for Tat.
During the first 50 ns the Arg-9 peptides bind to the phos­
phate groups in the proximal layer of the lipid bilayer. The 
guanidinium groups of the Arg side chains make hydrogen­
bond contacts with various oxygen atoms of the lipid head- 
groups, and the peptide is partially immersed into the bilayer 
at the level of the glycerol groups. After 100 ns an Arg side
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FIGURE 1 Four snapshots of an MD simulation, (a) Lateral view 
showing how the peptides are bound to the membrane before translocation. 
(b) Translocation of an Arg amino acid surrounded by water molecules that 
nucleates the formation of a water pore, (c) Lateral view of the pore, trans­
located peptide surrounded by a dotted square line, and a translocating 
peptide circled by an oval dotted line, (d) Top view of the pore. The phos­
pholipid molecules are represented with transparent white surfaces, the 
phosphate atoms are in yellow spheres, the peptide molecules are in red, 
any water molecule at a distance of <0.35 nm from any phospholipids or 
amino acid atom is colored in solid blue, and the rest of the water molecules 
appear as a transparent blue surface.
chain is attracted to a phosphate group in the distal layer of the 
bilayer. This phosphate group and the Arg side chain carry 
some water molecules with them, so they are never fully 
desolvated. During this period of time, a water chain crossing 
the bilayer is formed and a toroidal pore is nucleated. One of 
the Arg-9 peptides translocates by diffusing on the surface 
of the pore. In this calculation, the toroidal pore remains 
open toward the end of 500 ns. We speculate that the complete 
translocation of a peptide and closing of the pore will occur on 
the microsecond timescale; however, this was not explored in 
our calculations. The radius of the toroidal pore varies in size, 
having a maximum diameter of 2.5 nm. The pore surface is 
lined up with phosphate headgroups. The mechanism of 
Arg side-chain insertion and pore formation observed in the 
calculations with Arg-9 is identical to the mechanism found 
for the Tat peptide (19).
The destabilization of lipid membranes and the formation 
of pores induced by these peptides should lead to an increase 
in the ionic permeability of phospholipid bilayers and the 
cell membrane. To validate this prediction of the model, 
we experimentally investigated the permeabilizing effects 
of Arg-9 in planar lipid membranes and mammalian cells 
using two electrophysiological setups as described below.
Permeabilization of model lipid membranes
If CPPs are able to destabilize phospholipid bilayers, 
producing transient pores across them, then ionic permeabi­
lization should be observed. To test this hypothesis on model 
lipid membranes, we made phospholipid bilayers using the 
planar lipid bilayer (also known as the black lipid membrane) 
method (35). The basic idea of this setup is described in 
Fig. S1. The addition of micromolar concentrations of Arg-9 
to the aqueous solution bathing a planar bilayer membrane 
led to an increase of membrane conductance in all experi­
ments (>50 experiments). Fig. 2 a shows the permeabiliza­
tion of a phospholipid bilayer composed of a lipid mixture 
of DOPC/DOPG (3:1) after the addition of Arg-9 at a concen­
tration of 7 qM to the cis chamber. After the peptide is added 
to the cis chamber, the ionic permeabilization across the 
membrane increases. A similar effect is shown in Fig. 2 c 
for bilayers composed entirely of DOPC phospholipid 
molecules. This proves that anionic phospholipids such as 
DOPG are not strictly required for peptide permeabilization 
of the bilayer, since the peptides are still able to interact and 
permeabilize purely zwitterionic DOPC phospholipid bila­
yers. The permeabilization increases both continuously and 
with discrete jumps. The recordings show that the perme­
ability increases and reduces several times until finally the 
membrane breaks permanently. The transient current spikes 
were quite abrupt and most of the time did not resemble 
recordings of well-defined ionic channels, such as voltage­
dependent ion channels.
FIGURE 2 Permeabilization of phospholipid bilayers composed of a lipid 
mixture of DOPC/DOPG (3:1) (a and b) after the addition of 7qM of Arg-9 
to the cis chamber, (c) phospholipid bilayer composed entirely of DOPC, (d) 
lipid mixture of DOPC/DOPG (the CaCl2 ions are added to the solution 
before the addition of the peptide), (e) control measurement on a lipid 
mixture of DOPC/DOPG with addition of the Dap-9 peptide, and (f) control 
measurement on a lipid mixture of DOPC/DOPG without peptides. The 
arrow’s origin indicates the time at which the peptides or CaCl2 were added 
to the solution. The potential of the cis chamber relative to the trans chamber 
(the holding potential) is 50 mV. The ionic concentration is 100 mM of KC1 
and the pH is 7.4.
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Positive ions, such as divalent Ca21 ions, would be 
expected to displace the Arg amino acids or screen the under­
lying membrane phosphate groups. The permeability of the 
plasma membrane produced by the peptides should therefore 
be reduced upon the addition of calcium chloride. Indeed, as 
shown in Fig. 2 b, when calcium chloride was added to the 
solution, the permeabilization of the membrane reduced to a 
low baseline level. Moreover, as shown in Fig. 2 d. when the 
peptides were added after the addition of 100 mM of CaCb 
to the solution, there was no increase in the permeability of 
the bilayer, consistent with the ability of the Ca2 1 ions to 
mask the phosphate groups from the peptides. This finding 
highlights the importance of electrostatic interactions in the 
initiation of pore formation.
We expect Dap-9 to represent a reasonable negative 
control peptide. There is substantial experimental evidence 
indicating that poly-Lys CPPs translocate much less effi­
ciently than poly-Arg CPPs. The MD simulations also 
suggest that reducing the length of the amino acid side chain 
will dimmish the efficiency of the peptide translocation. 
Therefore, we tested the effect of Dap-9 (composed of nine 
2,3-diaminopropanoic acid residues (Fig. S3)), which has 
the same charge as Arg-9 but much shorter side chains and 
amine groups instead of guanidinium groups. As shown in 
Fig. 2 e, Dap-9 does not permeabilize the phospholipid 
membrane. We also performed a negative control (Fig. 2 f) 
using the same solution but with no peptide addition, and 
no current increase was observed.
Fig. 3 a shows the current induced by Arg-9 across the 
bilayer for a system with the same composition and held at 
the same voltage as in Fig. 2 a. Fig. 3, b and c, show the 
dependence of the current on the voltage. Each interval char­
acterizes a common state observed during the permeabiliza­
tion of the membrane: control I/V represents a control 
measurement before the peptide is added, I/V (i) is a measure­
ment after the addition of the peptide but before the steady 
increase of the conductance across the bilayer, and I/V (ii) 
is a measurement during the steady increase of conductance 
across the lipid bilayer. As shown in the figure, current fluc­
tuations were seen initially after the peptides were added, but 
the baseline current remained unchanged and there was no 
significant difference in the average current versus voltage 
recorded (Fig. 3 b, I/V (i)) compared to the same measure­
ment obtained before addition of the peptides (Fig. 3 b, I/V 
control). However, after a few minutes the permeabilization 
became permanent (the current baseline increased) and there 
was a marked increase in slope of the current versus voltage 
for I/V (ii) relative to that for control I/V. In Fig. 3, a and c, 
it can be seen that after the addition of 100 mM of CaCE, 
the permeability decreased. Furthermore, after a period of 
>100 min, the permeability dropped to very low baseline 
values, as can be seen in Fig. 3 c, I/V (iv).
These results can be interpreted in the following way: 
After the peptides are added to the solution, they start to 
bind the bilayer, creating isolated local transient pores across 
the bilayer. Consequently, the current baseline initially 
remains at the same level as that before addition of Arg-9. 
The slope of the current versus voltage plot in I/V (i) remains 
almost unchanged compared to that for the I/V control, indi­
cating that the permeability increases transiently while the 
baseline remains unchanged most of the time. After a few 
minutes, the surface density of membrane-bound peptides 
increases, destabilizing the membrane more strongly and 
permanently, as reflected by the increase in the baseline 
current at I/V (ii) and by the increase in the slope of the 
current versus voltage. After the addition of CaCl2, the 
permeability decreases, indicating that Ca2 1 ions may be 
competing for phosphate groups and displacing the Arg-9 
FIGURE 3 Current across a planar lipid bilayer under 
the same conditions as in Fig. 2, c and d. (a) An average 
over 10 measurements of current as a function of voltage 
that were carried out at six different time points: (I/V 
control) before adding the peptides, (I/V (i)) 10 min after 
adding the peptide, (I/V (ii)) 40 min after adding the 
peptide, (I/V (iii)) 30 min after adding CaCl2, and (I/V 
(iv)) 70 min after adding CaCl2. The inset pictures show 
amplified sections of the current trace; the scaled time frac­
tion is enclosed by a dotted square, and when time and 
current are both scaled, the scale is included in the inset 
picture, (b and c) Average current as a function of voltage. 
The voltage is incremented by 10 mV between —90 mV to 
90 mv and the potential is held for 150 ms at each voltage. 
The points in b and c are the average over 10 consecutive 
measurements taken at each of the intervals indicated in a. 
It can be seen that after the peptide is added, there are 
currents jumps before (I/V (i)), but there is not much differ­
ence in average between I/V control and (I/V (i)). However, 
after the permeabilization becomes permanent and the 
baseline current starts to increase, there is a marked 
increase in the slope of the current versus voltage (I/V (ii)) relative to the control I/V (I/V control). After addition of CaCl2, the ionic permeabilization reduces. 
In the last I/V record (I/V (iv)), the current is even lower than the control current. This indicates that CaCl2 reduces the permeability of the membrane to 
essentially zero.
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peptides from the surface of the membrane. This results in 
the resealing of the phospholipid bilayer.
The insets of Figs. 3 and 4 show amplified current traces. 
One can see discrete current jumps that resemble the 
behavior of ion channels in cells, and rapidly fluctuating 
current jumps that can be clearly distinguished from most 
ionic channels. The latter types of signals can be used as 
a footprint to recognize the peptide interaction with the cell 
membrane, in addition to the expected steady permeabiliza­
tion increment with time.
Our measurements show that most of the time the current 
fluctuates rapidly; however, in some cases, more stable 
current jumps that resemble ion channels can be observed. 
If we assume that these jumps are associated with the forma­
tion of stable pores across the membrane, we can estimate the 
average radius of these pores by measuring the conductance. 
To characterize this behavior, we show in Fig. S4 a histogram 
of the amplitude of those current jumps over 118 events. 
Assuming that the pore conductivity is equal to that of 
100 mM of KC1, we can calculate the pore radius for a 
conductance G of 4.6 pA/50 mV = 0.92 10 10 S using 
a = Gh/A. where a is the conductivity (-1.6 S m A is 
the area of the pore, G is the conductance (-0.92 10 10 S), 
and h is the membrane thickness (-6 nm). The estimated 
pore diameter for this current value is d ~ 2 yj^Gh/ffir) = 
0.66 nm, which compares well with the pore diameter 
observed in the simulations.
FIGURE 4 Fractions of current traces after the addition of 7¿¿M of Arg-9 
to the cis chamber as the time progresses. The planar lipid bilayer is 
composed of a lipid mixture of DOPC/DOPG (3:1). It can be seen that as 
the time increases, the permeabilization has a noisier trend.
Although Arg-9 is the focus of this experimental work, we 
are currently investigating the effects of Tat, penetratin, and 
PG-1. Tat is also a highly hydrophilic CPP, penetratin is a 
slightly amphiphilic CPP, and PG1 is a pore-forming, Arg­
rich, amphiphilic antimicrobial peptide. We also observed 
in all these cases an increase in the permeabilization of the 
phospholipid bilayers upon addition to a final concentration 
of7juM(Fig. S5).
Permeability across mammalian cells
The results obtained in lipid bilayers encouraged us to test the 
peptide’s effects on cell membranes of human smooth muscle 
cells and osteosarcoma cells, although these systems are 
structurally and functionally much more complex. To accom­
plish this task, we used the patch-clamp technique in different 
configurations (whole-cell, cell-attached, and inside-out, as 
described in the Supporting Material) to measure ionic 
currents induced by the peptide on the cell membrane.
Whole cell: global permeabilization of the cell
We studied the effects of Arg-9 on isolated HUA smooth 
muscle cells in the whole-cell configuration (Fig. S2). Fig. 5 
a shows a typical time course of the current at —50 mV, 
where we see that the addition of the peptide caused a slow 
increased in the magnitude of this inward current. The effects 
of both concentrations of Arg-9 varied among the cells tested, 
and some of them did not show any significant changes 
(five out of seven cells tested for 0.07 gM. and two out of 
nine cells tested for 7 qM ). In the cells in which the peptide 
produced an effect, the average holding current showed 
a significant increase over the control current measured in 
the absence of the peptide. The mean current increase induced 
by 7 qM concentration of Arg-9, expressed as a percentage of 
the control current, is 126% ±45% (n = 7). We also observed 
that Arg-9 induced instantaneous current jumps like the ones 
shown in Fig. 5 b. A similar behavior could also be observed 
at other membrane potentials (data not shown).
It is known that acidification of the extracellular medium 
can destabilize phospholipid bilayers, thereby enhancing 
the destabilizing effects induced by the peptide on the plasma 
membrane. Therefore, we tested the peptide’s effect on 
the holding current at —50 mV in an acid bath solution 
(pH = 5.5). Under this condition we tested nine HUA 
smooth muscle cells, and in six of them the current increased 
to a much greater extent than at the physiological pH of 7.4. 
The mean current increase (Fig. 5, c and ¿7) was in this case 
460% ± 130% (averaged over six experiments).
Cell-attached and inside-out: local cell 
permeabilization
We next tested the effect of Arg-9 on cells in the cell- 
attached and inside-out configurations. These configurations 
allowed us to measure the currents induced by the peptide in
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FIGURE 5 (a) Time course of the increase of the inward 
membrane current after the addition of 7 ¿¿M of Arg-9 to 
the extracellular solution in the whole-cell configuration 
in the case of HUA smooth muscle cells, (b) Three typical 
recordings of this current (pH 7.4), corresponding to the 
points i, ii, and iii indicated in a and c. If the pH of the 
bath solution is lowered to 5.5, the increase in the inward 
current is more prominent. (J) Three typical recordings 
of this current, corresponding to the points i, ii, and iii indi­
cated in c.
membrane areas that are small compared to the whole 
surface of the cell.
In Fig. 6 we can observe several recordings of the current 
evoked by a concentration of 7 (iM of Arg-9 in the pipette at 
different times after the seal was obtained in HUA smooth 
muscle cells. A concentration of 0.07 (iM of the peptide 
was also tested (data not shown), with similar results.
In the majority of tested HUA smooth muscle cells, after 
periods of time ranging from 10 to 35 min, we began to 
observe rapidly fluctuating current jumps that resembled 
the ones we previously observed in artificial phospholipid 
bilayers. These signals do not follow a repetitive pattern 
and are difficult to characterize by the typical parameters 
used to study ionic channels, such as mean current ampli­
tude, open probability, or dwell times. Instead, they resemble 
the current patterns observed on perturbed membranes of 
different kinds of cells exposed to mechanical stress 
(43,44) or in cardiac cells stimulated by photosensitizer­
generated reactive oxygen species (45). This characteristic 
signal can be observed in six out of seven cells obtained 
from different samples of umbilical cords, although the effect 
of the peptide is variable in magnitude. We also observed 
similar rapidly fluctuating current jumps in some of our 
control cells (without peptide in the pipette), albeit with 
a much lower frequency of appearance than in the presence 
of Arg-9. Cell-attached experiments with the peptide 
(0.07 qM) were also made in UMR106 osteosarcoma cells 
with similar results.
Fig. 7 shows current snapshots that compare the evolution 
of current with time for osteosarcoma, HUA smooth muscle 
cells, and phospholipid bilayers. It can be seen that in every 
case the ionic currents observed demonstrate a time­
increasing, rapidly fluctuating behavior. In the case of the 
phospholipid bilayer, a stepwise current can also be seen
FIGURE 6 Typical cell-attached recordings of the current evoked by the 
peptide placed inside the pipette in HUA smooth muscle cells at different 
times after the seal was obtained.
Biophysical Journal 97(7) 1917-1925
Permeabilization by Arg-Rich Peptides 1923
cell muscle cell bilayer
a Osteosarcoma b HUA smooth c Phospholipid
c□
-■s
^5
■ia mua Ajtfri - -jiAn.MMMMMOTMMBMKMMiM <Wr^irTWWW’’F"
6 _______ I I Hh|MN I' W I I!1 "
.«m ■ '■ i^iÀàUmmi ^^JitaiJUiL
■■..-... ... '
■uuAwki 
R**wf*l 
kkiuAu, iiMka< Œ
O
FIGURE 7 Snapshots of typical recordings of the current evoked by the 
peptide (placed inside the pipette) at different times after the seal was 
obtained in the cell-attached configuration in (a) an osteosarcoma cell, (b) 
an HUA smooth muscle cell, and (c) a phospholipid bilayer. It can be 
seen that as the time increases, the membrane is increasingly permeabilized, 
and the signal reflects a rapidly fluctuating current in every case.
that resembles the opening behavior of ionic channels. 
However, if the peptides produce discrete jumps in the cells, 
these would not be easily distinguished from those belonging 
to the ion channels already present in the cells. Hence, to mini­
mize the activation of voltage-operated channels, we tested 
the effects of the peptide using a —50 mV membrane potential 
at which, in these kinds of cells, most of these voltage-oper­
ated ionic channels present a low open probability.
In the inside-out configuration, a micrometer portion of 
the cell surface was covered by the tip of the glass pipette; 
it was then was pulled out and only a small piece of the 
membrane remained in contact with the pipette. In this 
configuration, the internal surface of the cell membrane 
was exposed to the bath solution. EGTA (1 mM), a calcium 
chelator, was used to inhibit the activity of calcium-depen­
dent ionic channels. As in the case of the cell-attached 
configuration, the recordings were obtained in a symmetric 
high-potassium saline solution. When a transmembrane 
potential of —50 mV (outside positive) was applied, a stable 
holding current appeared. Immediately after the addition of 
Arg-9 to a concentration of 7 gM to the bath solution 
(now in contact with the intracellular side of the membrane), 
the negative net current measured at —50 mV significantly 
changed reaching more positive current values (Acurrent = 
75 ± 18 pA, n = 13). After that, we again observed the 
occurrence of rapidly fluctuating, unstable, variable current 
jumps, such as those observed in the last part of the recording 
shown in Fig. 8. These two kinds of behaviors were seen 
only in the presence of Arg-9 and were similar in all 13 cells 
tested. They were not observed in the control inside-out 
patches. The peptide effect seems to have two phases in 
this patch-clamp configuration: an immediate improvement 
of seal resistance, followed by an increase of the patch noise, 
reflecting the destabilizing effect observed in the other 
configurations. This could be partially explained by the 
observations made by Chico et al. (46), who reported that 
significant amounts of poly-D-Arg are retained by plastic 
and glass surfaces. This finding could explain our results, 
because Arg-9 would be able to improve the seal by 
increasing the interaction between the cell membrane and 
the glass pipette, which is the base of the establishment of 
a high-resistance seal. This effect does not exclude the fact 
that Arg-9 can then penetrate by destabilizing the cell 
membrane, as can be inferred by the occurrence of the typical 
noisy currents, even though the effective peptide concentra­
tion is much less than the 7 gM that is the initial peptide 
concentration.
CONCLUSIONS
We have shown experimentally that Arg-9 peptides destabi­
lize and permeabilize planar phospholipid bilayers and cell 
membranes, consistent with our theoretical model.
We performed an MD simulation of Arg-9 that reproduces 
the main steps for translocation previously observed for the
FIGURE 8 Typical recording of Arg-9 effects in an inside-out patch 
obtained from an HUA smooth muscle cell in symmetrical ionic conditions, 
(¿z) A recording showing the current measured at 50 mV (outside negative) 
and its decrease induced by the Arg-9 addition at a concentration of 7 ¿¿M. 
After a few minutes, the current trace becomes rapidly fluctuating in the 
presence of the peptide. The variability of these current jumps can be 
observed in the three traces of panel b extracted at different time intervals.
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Tat peptide (19). The peptides bind to the surface of the 
bilayer, attracted by the phosphate groups of the phospho­
lipids. The interactions produce large local distortions to 
the phospholipid bilayer in comparison with its resting struc­
ture, and reduce the free-energy barrier as an Arg side chain 
translocates attracted by phosphate groups on the distal side. 
This helps the nucleation and the formation of a toroidal 
pore. Once the pore is formed, the peptides translocate by 
diffusing on the surface of the pore. The simulations high­
light the central role of the Arg side chains in accordance 
with experimental evidence (47) showing that six or more 
guanidinium groups are required to efficiently penetrate the 
cell membranes.
Despite intense research, the details of the cell penetration 
mechanism of poly-Arg peptides are still under discussion. 
Futaki and co-workers (48) recently reviewed the subject 
and concluded that proteoglycans may play a crucial role 
as primary receptors for peptide internalization, and that 
both endocytosis and direct membrane translocation are 
possible entry routes for Arg-rich peptides. Still, some of 
the most important points that remain to be determined are 
whether the process is dependent on cell metabolic energy, 
and whether it requires vesicle formation (i.e., endocytosis 
(49) and macropinocytosis (50), among others). There is 
experimental evidence that the uptake of poly-Arg can be 
inhibited by blocking the cell metabolism with sodium azide 
(47), lowering the temperature to 4°C (51), or using macro- 
pinocytosis and endocytosis inhibitors (11,50,52). However, 
other reports suggest that cell penetration is independent 
of metabolic cell energy. For example, knocking down 
clathrin-mediated and caveolin-mediated endocytosis (53) 
does not affect the ability of Tat to enter cells. The results 
presented here can explain the observations of direct translo­
cation of the peptides through a mechanism that is indepen­
dent of metabolic cell energy.
Our theoretical observations show that Arg-9 is able to 
nucleate transient pores that would allow ions to flow across 
it. Therefore, applying an electrostatic potential across the 
bilayer should induce a net ionic current that could be 
detected experimentally. We confirmed this prediction by 
measuring currents across planar phospholipid bilayers and 
both cultured and freshly isolated mammalian cells.
The electrostatic attraction between the Arg amino acids 
and the phosphate groups of the membrane is a pivotal 
step in the translocation model. Therefore, different ions 
would have a strong effect on the translocation of these 
peptides if they were able to screen these interactions. If 
the CaCb concentration is increased after addition of the 
peptides, the permeabilization initiated by Arg-9 will be 
strongly reduced. We speculate that calcium ions may be 
competing for the phosphate groups, thereby reducing the 
binding of the peptides to the surface of the membrane.
We have demonstrated, using theoretical and experimental 
methods, that a peptide made up entirely of Arg residues is 
able to interact and permeabilize biological membranes.
Furthermore, we have shown that the length of the side chains, 
and the guanidinium group and ions present can have 
a profound effect on the ability of these peptides to cross the 
membrane. Understanding the mechanism by which CPPs 
disrupt the plasma membrane will contribute to our funda­
mental knowledge of the mechanisms behind internalization 
of charged molecules through lipid membranes, and the 
design of more efficient cargo-carrying molecules, which 
could lead to better drug-delivery candidates.
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